PROFIL KADAR ANTIBODI LEPROSY INFECTIOUS DISEASE RESEARCH INSTITUTE (IDRI) DIAGNOSTIC-1 (LID-1) PADA PASIEN KUSTA DAN NARAKONTAK SERUMAH PASIEN KUSTA MULTI BASILER DI DIVISI KUSTA UNIT RAWAT JALAN (URJ) KESEHATAN KULIT DAN KELAMIN RSUD DR. SOETOMO SURABAYA
Background: Leprosy is caused by Mycobacterium leprae infection and remains a major public health problem in many areas of the world. Although PGL-1 antigen has been reported as auxiliary diagnostic tool, currently there is no serological assay routinely used in leprosy diagnosis. LID-1 antigen h...
Saved in:
| Main Author: | |
|---|---|
| Format: | Theses and Dissertations NonPeerReviewed |
| Language: | English English |
| Published: |
2018
|
| Subjects: | |
| Online Access: | http://repository.unair.ac.id/69015/1/abstrak.pdf http://repository.unair.ac.id/69015/2/full%20text.pdf http://repository.unair.ac.id/69015/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Universitas Airlangga |
| Language: | English English |
| Summary: | Background: Leprosy is caused by Mycobacterium leprae infection and
remains a major public health problem in many areas of the world. Although
PGL-1 antigen has been reported as auxiliary diagnostic tool, currently there is
no serological assay routinely used in leprosy diagnosis. LID-1 antigen has
showed potential to improve diagnostic capacity at local health centers and aid
development of strategies for the eventual control and elimination of leprosy
from endemic areas.
Purpose: To determine LID-1 antibody level in leprosy patients and household
contacts at Dermato-venereology outpatient clinic, dr. Soetomo teaching
hospital, Surabaya.
Method: Sera from 35 leprosy patients (8 PB type and 27 MB type) and 22
household contacts were evaluated using Enzyme Linked Immunosorbent
Assay (ELISA) with LID-1 antigen. Clinical form and bacterial index (BI) were
recorded and analyzed to correlate with the LID-1 antibody levels.
Results: There were 3 from 5 PB leprosy patients (60%) and 25 from 27 MB
leprosy patients (93%) showed anti LID-1 seropositivity with mean value for
PB leprosy patients 0,136±0,023 OD unit and for MB leprosy patients
0,710±0,524 OD unit. Household contacts revealed 10 from 25 people (40%)
showed anti LID-1 seropositivity with mean value 0,065±0,025 OD unit.
Conclusions: Detection of antibody against LID-1 in leprosy patients showed
LID-1 antigen as a potential serodiagnosis of leprosy. It is well established that
the earlier a leprosy patient is identified, the better their response to treatment.
Serological tests that do not require significant labor can detect asymptomatic
M. leprae infection may contribute to the control and eradication of leprosy.
Keywords: antibody, leprosy, LID-1 |
|---|